Paper39289508
Silencing the transcriptionally active HIV reservoir to improve treatment outcomes.
Prigann J and 9 others. Nat Microbiol, 2024. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Silencing the transcriptionally active HIV reservoir to improve treatment outcomes. Papers, record 39289508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39289508
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV Infections | Major topic |
| HIV-1 | Major topic |
| Humans | |
| Treatment Outcome | |
| Virus Latency | |
| Transcription, Genetic | |
| Anti-HIV Agents | |
| CD4-Positive T-Lymphocytes |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI167732 | NIAID NIH HHS | United States | R01AI167732 | PubMed | NIH RePORTER |
| R37 AI165137 | NIAID NIH HHS | United States | R37AI165137 | PubMed | NIH RePORTER |
| UM1 AI164559 | NIAID NIH HHS | United States | UM1AI164559 | PubMed and NIH | NIH RePORTER |
| UM1AI164559 | U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) | UM1AI164559 | PubMed and NIH | NIH RePORTER |
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32573496 | Filgotinib suppresses HIV-1-driven gene transcription by inhibiting HIV-1 splicing and T cell activation. | J Clin Invest | 2020 | https://conductscience.org/library/papers/32573496 | PubMed |
| 2 | 22817991 | An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription. | Cell Host Microbe | 2012 | https://conductscience.org/library/papers/22817991 | PubMed |
| 3 | 36599978 | HIV silencing and cell survival signatures in infected T cell reservoirs. | Nature | 2023 | https://conductscience.org/library/papers/36599978 | PubMed |
| 4 | 29491188 | HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing. | Sci Transl Med | 2018 | https://conductscience.org/library/papers/29491188 | PubMed |
| 5 | 36599977 | Phenotypic signatures of immune selection in HIV-1 reservoir cells. | Nature | 2023 | https://conductscience.org/library/papers/36599977 | PubMed |
| 6 | 36146786 | Forging a Functional Cure for HIV: Transcription Regulators and Inhibitors. | Viruses | 2022 | https://conductscience.org/library/papers/36146786 | PubMed |
| 7 | 38035854 | Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable Viremia. | J Infect Dis | 2024 | https://conductscience.org/library/papers/38035854 | PubMed |
| 8 | 32029589 | Defective HIV-1 proviruses produce viral proteins. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/32029589 | PubMed |
| 9 | 35026153 | Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses. | Cell | 2022 | https://conductscience.org/library/papers/35026153 | PubMed |
| 10 | 29045830 | In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a "Block-and-Lock" Strategy for HIV-1 Treatment. | Cell Rep | 2017 | https://conductscience.org/library/papers/29045830 | PubMed |
| 11 | 33239456 | The XPB Subunit of the TFIIH Complex Plays a Critical Role in HIV-1 Transcription and XPB Inhibition by Spironolactone Prevents HIV-1 Reactivation from Latency. | J Virol | 2021 | https://conductscience.org/library/papers/33239456 | PubMed |
| 12 | 30546110 | Intron-containing RNA from the HIV-1 provirus activates type I interferon and inflammatory cytokines. | Nat Commun | 2018 | https://conductscience.org/library/papers/30546110 | PubMed |
| 13 | 28416661 | Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28416661 | PubMed |
| 14 | 27681137 | Specific Inhibition of HIV Infection by the Action of Spironolactone in T Cells. | J Virol | 2016 | https://conductscience.org/library/papers/27681137 | PubMed |
| 15 | 33075121 | HIV-1 Transcription but Not Intact Provirus Levels are Associated With Systemic Inflammation. | J Infect Dis | 2021 | https://conductscience.org/library/papers/33075121 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42927123 | "Locking" CDK9 inhibition by activating integrator function in HIV transcription. | iScience | 2026 | https://conductscience.org/library/papers/42927123 | PubMed |
| 42900669 | Selective persistence of HIV-1-infected T cell clones can occur through immune reprogramming driven by defective, transcriptionally active proviruses. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42900669 | PubMed |
| 42713136 | Residual HIV activity and host immunometabolic remodeling during antiretroviral therapy: implications for cardiovascular-kidney-metabolic risk. | Front Immunol | 2026 | https://conductscience.org/library/papers/42713136 | PubMed |
| 41864210 | Multiomic analysis of ART-interruption cohorts identifies cell-extrinsic and -intrinsic mechanisms driving lymphocyte-mediated control of HIV rebound. | Immunity | 2026 | https://conductscience.org/library/papers/41864210 | PubMed |
| 41600872 | Tools to Quantify and Characterize the Persistent Reservoir in People with HIV-1: Focus on Non-B Subtypes. | Viruses | 2026 | https://conductscience.org/library/papers/41600872 | PubMed |
| 41143136 | Meeting Summary for Keystone Symposia on HIV Cure: Antiretroviral Therapy (ART)-Free Control of HIV Infection in Durban, South Africa, 2025. | Pathog Immun | 2025 | https://conductscience.org/library/papers/41143136 | PubMed |
| 39903363 | Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places. | Curr HIV/AIDS Rep | 2025 | https://conductscience.org/library/papers/39903363 | PubMed |
| 39459922 | Interventions during Early Infection: Opening a Window for an HIV Cure? | Viruses | 2024 | https://conductscience.org/library/papers/39459922 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39289508
GET https://conductscience.org/api/papers/v1/39289508/authors